BETA CAT PHARMACEUTICALS, INC.

Profile

Company Names

BETA CAT PHARMACEUTICALS, INC.

Addresses

2450 WEST HOLCOMBE BLVD, HOUSTON, TX 77021

2450 HOLCOMBE BLVD. EAST, SUITE J-606, HOUSTON, TX 77021

7000 FANNIN STREET, SUITE 1930, HOUSTON, TX 77030

22 FIRSTFIELD ROAD, SUITE 280, GAITHERSBURG, MD 20878

Phone Numbers

317-517-9500
2816508038
3175179500

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

2014

State Incorporated:

DELAWARE

Total Amount Raised:

$5,544,479.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2018-06-12 
$2,600,000.00 
$6,000,000.00 
$3,400,000.00 
Equity 
3
2016-07-25 
$1,404,918.00 
$1,404,918.00 
$0.00 
Equity 
2
2015-06-18 
$1,039,561.00 
$3,035,583.00 
$1,996,022.00 
Equity 
1
2014-06-19 
$500,000.00 
$500,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RAHUL 
 
ARAS 
EXECUTIVE OFFICER
SIRONRX THERAPEUTICS, INC.   |  JUVENTAS THERAPEUTICS INC   |  BETA CAT PHARMACEUTICALS, INC.
UMA 
 
BHATT 
EXECUTIVE OFFICER
BETA CAT PHARMACEUTICALS, INC.   |  STINGRAY THERAPEUTICS, INC.
ALAIN 
 
CAPPELUTI 
EXECUTIVE OFFICER
NEXIMMUNE, INC.   |  NOBLE LIFE SCIENCES, INC.   |  CAVITRONIX CORP   |  BETA CAT PHARMACEUTICALS, INC.
KENNETH 
 
CARTER 
DIRECTOR
NEODIAGNOSTIX INC   |  NEXIMMUNE, INC.   |  NOBLE LIFE SCIENCES, INC.   |  BETA CAT PHARMACEUTICALS, INC.   |  SENECA BIOPHARMA, INC.   |  BITMOVIN, INC.
KENNETH 
C 
CARTER 
DIRECTOR
BETA CAT PHARMACEUTICALS, INC.   |  NEUIMMUNE, INC.
CASEY 
 
CUNNINGHAM 
EXECUTIVE OFFICER
TERAPIO CORP   |  MOLECULAR TEMPLATES, INC.   |  ABVITRO INC   |  BETA CAT PHARMACEUTICALS, INC.   |  LYRIC PHARMACEUTICALS INC.   |  GENEOS THERAPEUTICS, INC.   |  GLYSCEND, INC.   |  SEEING MEDICINES, INC.   |  TEN BAY BIO, INC.
JOE 
 
CUNNINGHAM 
DIRECTOR
D5 PHARMA, INC.   |  MILLIPEDE, INC.   |  BETA CAT PHARMACEUTICALS, INC.   |  REMEDY APPLICATIONS INC.   |  BIOSTABLE SCIENCE + ENGINEERING INC   |  CLAIRITY, INC.
JOSEPH 
 
CUNNINGHAM 
DIRECTOR
FX BRIDGE TECHNOLOGIES CORP   |  RENEW LENDING, INC.   |  BETA CAT PHARMACEUTICALS, INC.
JAMES 
 
EADIE 
DIRECTOR
CLARET MEDICAL, INC.   |  TVA MEDICAL, INC.   |  IOWA APPROACH, INC.   |  MILLIPEDE, INC.   |  BETA CAT PHARMACEUTICALS, INC.   |  FARAPULSE, INC.   |  DYAMX, INC.   |  GENEOS THERAPEUTICS, INC.   |  REPRIEVE CARDIOVASCULAR, INC.   |  PULSEON, INC.   |  RAPIDPULSE, INC.   |  ENDOGENEX, INC.   |  ABK BIOMEDICAL INC   |  CRYOSA, INC.
STEPHEN 
 
HORRIGAN 
EXECUTIVE OFFICER
BETA CAT PHARMACEUTICALS, INC.
SCOTT 
 
JORDAN 
EXECUTIVE OFFICER, DIRECTOR
CENTRAL LOGIC, INC.   |  BETA CAT PHARMACEUTICALS, INC.
JONATHAN 
 
NORTHRUP 
EXECUTIVE OFFICER, DIRECTOR
CONVERGENE LLC   |  SALARIUS PHARMACEUTICALS, LLC   |  BETA CAT PHARMACEUTICALS, INC.
JONATHAN 
P 
NORTHRUP 
EXECUTIVE OFFICER, DIRECTOR
BETA CAT PHARMACEUTICALS, INC.
JONATHAN 
P. 
NORTHRUP 
EXECUTIVE OFFICER, DIRECTOR
BETA CAT PHARMACEUTICALS, INC.   |  STINGRAY THERAPEUTICS, INC.
SUNIL 
 
SHARMA 
EXECUTIVE OFFICER, DIRECTOR
BETA CAT PHARMACEUTICALS, LLC   |  CONVERGENE LLC   |  BETA CAT PHARMACEUTICALS, INC.   |  SALARIUS PHARMACEUTICALS, LLC   |  STINGRAY THERAPEUTICS, INC.   |  ZACAPA RESOURCES LTD.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-06-27
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-12 
2017-12-18
D
Link
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2016-07-25 
2015-07-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-18 
2014-07-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-06-19 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
N/A
NONE